These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34825871)

  • 1. Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD.
    Bryant AG; Manhard MK; Salat DH; Rosen BR; Hyman BT; Johnson KA; Huang S; Bennett RE; Yen YF
    Curr Alzheimer Res; 2021; 18(9):711-720. PubMed ID: 34825871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant vascular architecture in the hippocampus correlates with tau burden in mild cognitive impairment and Alzheimer's disease.
    Lee H; Fu JF; Gaudet K; Bryant AG; Price JC; Bennett RE; Johnson KA; Hyman BT; Hedden T; Salat DH; Yen YF; Huang SY
    J Cereb Blood Flow Metab; 2024 May; 44(5):787-800. PubMed ID: 38000018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of tau deposition using
    Bullich S; Mueller A; De Santi S; Koglin N; Krause S; Kaplow J; Kanekiyo M; Roé-Vellvé N; Perrotin A; Jovalekic A; Scott D; Gee M; Stephens A; Irizarry M
    Alzheimers Res Ther; 2022 Jul; 14(1):105. PubMed ID: 35897078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography.
    Kilroy E; Apostolova L; Liu C; Yan L; Ringman J; Wang DJ
    J Magn Reson Imaging; 2014 Apr; 39(4):931-9. PubMed ID: 24038544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cortical capillary transit time heterogeneity in Alzheimer's disease: a DSC-MRI perfusion study.
    Eskildsen SF; Gyldensted L; Nagenthiraja K; Nielsen RB; Hansen MB; Dalby RB; Frandsen J; Rodell A; Gyldensted C; Jespersen SN; Lund TE; Mouridsen K; Brændgaard H; Østergaard L
    Neurobiol Aging; 2017 Feb; 50():107-118. PubMed ID: 27951412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.
    Albrecht D; Isenberg AL; Stradford J; Monreal T; Sagare A; Pachicano M; Sweeney M; Toga A; Zlokovic B; Chui H; Joe E; Schneider L; Conti P; Jann K; Pa J
    J Neurosci; 2020 Oct; 40(44):8573-8586. PubMed ID: 33046556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between long-term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using
    Li J; Zheng C; Ge Q; Yan S; Paranjpe MD; Hu S; Zhou Y;
    J Neurosci Res; 2022 Feb; 100(2):670-680. PubMed ID: 34882830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Nielsen RB; Egefjord L; Angleys H; Mouridsen K; Gejl M; Møller A; Brock B; Brændgaard H; Gottrup H; Rungby J; Eskildsen SF; Østergaard L
    Alzheimers Dement; 2017 Oct; 13(10):1143-1153. PubMed ID: 28343848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease.
    Madsen LS; Parbo P; Ismail R; Gottrup H; Østergaard L; Brooks DJ; Eskildsen SF
    Neurobiol Aging; 2023 Mar; 123():1-9. PubMed ID: 36610198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging.
    Rauchmann BS; Ghaseminejad F; Mekala S; Perneczky R;
    Radiology; 2020 Jul; 296(1):134-142. PubMed ID: 32368960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
    Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.